Biological
ASP3772 clinical trials
Also written ASP3772.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
23-valent pneumococcal capsular polysaccharide vaccine (1) · Pneumococcal Vaccines (1) · Intramuscular Route of Administration (1)
Studies
Open first, then newest update. How each study uses ASP3772 is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal VaccineCompletedPhase 1/2GlaxoSmithKlineNCT03803202Written as ASP3772
- A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active ComparatorCompletedPhase 1Affinivax, Inc.NCT04525599Written as ASP3772
- Single Ascending Dose of ASP3772 Study in Japanese Healthy Male and Female Adults, and Single Ascending Dose Study of ASP3772 in Comparison With PPSV23 in Japanese Elderly Male and Female SubjectsCompletedPhase 1Affinivax, Inc.NCT04265911Written as ASP3772 (subcutaneous)